immunological and systemic disorders. Recently, H. pylori were associated with insulin resistance and obesity 3 .
The prevalence of H. pylori infection in obese patients is still controversial. Many studies demonstrated a low prevalence of H. pylori in obese patients, others reported high prevalence and some found an increase in body mass index (BMI) after H. pylori eradication [4] [5] [6] .
The aim of this study is to evaluate the prevalence of H. pylori in obese and non-obese patients.
METHOD
One hundred obese (endoscopy evaluation before bariatric surgery) and 100 non-obese subjects (endoscopy screening) were included in the study. Informed consent was obtained from the participants.
Inclusion criteria were as follows: 100 obese subjects with body mass index (BMI) ≥30 kg/m 2 and 100 non-obese subjects with 18.5> BMI <25 kg/m 2 according to WHO criteria. 
DISCUSSION
The significance of H. pylori infection in obese patients is debatable; its relation to BMI has been evaluated in several studies.
In our study, a high prevalence of infection was seen in 27-49 years of age. In a study done by Marusic et al, the majority of H. pylori-infected patients were 45-64 years 7 .
In our study, the prevalence of H. pylori in obese female patients was 71% compared to 29% in obese male patients, and 64% compared to 36% in non-obese patients. In a study by Ghadimi et al, H. pylori infection was 78% and 82% for males and females, respectively 8 . Marusic et al found that there was female predominance, and the male to female ratio was 0.92 7 .
We found that fatty liver is more common in H. pylori positive patients. H. pylori infection was considered a risk factor for the development of non-alcoholic fatty liver disease (NAFLD) because of its link with the pathogenesis of insulin resistance (IR) 9 .
H. pylori were more prevalent in obese patients than nonobese, it is similar to the result by Arslan et al who found that prevalence of H. pylori in obese patients was 66.2%, and in non-obese 35.2%
10 . The high prevalence of H. pylori in obese patients is attributed to the alteration of the innate and adaptive immunity which is usually found in obesity because morbidly obese patients have less mature monocytes, low macrophages and reduced polymorphonuclear (PMN) bactericidal capacity 10 . In morbidly obese, there is a significant reduction in natural killer cells activity when compared to normal individuals matched for age and gender 11 .
Another study suggested a suppression of peripheral blood mononuclear cells chemokine and cytokine production, with subsequent reduction of the immune response to infectious agents 12 . Moreover, animal studies have also suggested immune dysfunction in obese animals leading to an altered response to both bacterial and viral infection 13 .
On the other hand, some studies found that H. pylori infection reduce the ghrelin secretion and consequently decreases appetite, and they noticed increased weight after H. pylori eradication with demonstrated increased plasma ghrelin levels 6, 14 .
The difference in the results of previous research may be attributed to using different testing modalities for H. pylori because serologic testing is less sensitive and specific (85% and 79%) compared to histology (>95% for both) and is considered inferior to rapid urease test for the diagnosis of H. pylori, because antibodies remain positive whether the infection is active or resolved 15 . The Prevalence of Helicobacter Pylori Infection in Obese and Non-Obese Subjects Attending the Endoscopy Unit
CONCLUSION

